<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39356325</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8491</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>European archives of psychiatry and clinical neuroscience</Title><ISOAbbreviation>Eur Arch Psychiatry Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Effects of cognitive training and group psychotherapy on cognitive performance of post COVID-19 patients: an exploratory and non-randomized clinical trial.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00406-024-01904-x</ELocationID><Abstract><AbstractText>Cognitive complaints are common signs of the Post COVID-19 (PC) condition, but the extent and type of cognitive impairment may be heterogeneous. Little is known about neuropsychological treatment options. Preliminary evidence suggests cognitive symptoms may improve with cognitive training and naturally over time. In this clinical trial, we examined whether participation in a weekly group consisting of cognitive training and group psychotherapy is feasible and would exert beneficial effects on cognitive performance in PC and whether improvements were associated with intervention group participation or represented a temporal improvement effect during syndrome progression. 15 PC patients underwent an 8-week intervention. Cognitive performance was assessed before and after each intervention group participation. A control group of 15 PC patients with subjective neurocognitive or psychiatric complaints underwent two cognitive assessments with comparable time intervals without group participation. To attribute changes to the intervention group participation, interaction effects of group participation and time were checked for significance. This is an exploratory, non-randomized, non-blinded controlled clinical trial. Within the intervention group, significant improvements were found for most cognitive measures. However, significant time x group interactions were only detected in some dimensions of verbal memory and visuo-spatial construction skills. Significant time effects were observed for attention, concentration, memory, executive functions, and processing speed. The intervention setting was feasible and rated as helpful and relevant by the patients. Our results suggest that cognitive symptoms of PC patients may improve over time. Patients affected by both neurocognitive impairments and mental disorders benefit from group psychotherapy and neurocognitive training. The present study provides evidence for a better understanding of the dynamic symptomatology of PC and might help to develop further studies addressing possible therapy designs. The main limitations of this exploratory feasibility trial are the small sample size as well as the non-randomized design due to the clinical setting.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jebrini</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0006-6523-7633</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nussbaumstraße 7, 80336, Munich, Germany. tarek.jebrini@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Anabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nussbaumstraße 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sachenbacher</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nussbaumstraße 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heimkes</LastName><ForeName>Fides</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nussbaumstraße 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karch</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nussbaumstraße 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goerigk</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3021-0346</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nussbaumstraße 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charlotte Fresenius Hochschule, University of Psychology, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruzicka</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2451-1070</Identifier><AffiliationInfo><Affiliation>Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fonseca</LastName><ForeName>Gerardo Jesus Ibarra</ForeName><Initials>GJI</Initials><AffiliationInfo><Affiliation>Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wunderlich</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nussbaumstraße 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benesch</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pernpruner</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heindl</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Stabstelle Strategische Unternehmenssteuerung, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stubbe</LastName><ForeName>Hans Christian</ForeName><Initials>HC</Initials><Identifier Source="ORCID">0000-0002-7873-996X</Identifier><AffiliationInfo><Affiliation>Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uebleis</LastName><ForeName>Aline Olivia</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nussbaumstraße 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosse-Wentrup</LastName><ForeName>Fabienne</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nussbaumstraße 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adorjan</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7501-9556</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychiatric Phenomics and Genomics, LMU University Hospital, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Arch Psychiatry Clin Neurosci</MedlineTA><NlmUniqueID>9103030</NlmUniqueID><ISSNLinking>0940-1334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Cognitive training</Keyword><Keyword MajorTopicYN="N">Group psychotherapy</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39356325</ArticleId><ArticleId IdType="doi">10.1007/s00406-024-01904-x</ArticleId><ArticleId IdType="pii">10.1007/s00406-024-01904-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int . Accessed 12 Jun 2023</Citation></Reference><Reference><Citation>WHO Director-General’s opening remarks at the media briefing on COVID-19–11 (2020) https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 . Accessed 12 Jun 2023</Citation></Reference><Reference><Citation>Post COVID-19 condition (Long COVID) https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition . Accessed 12 Jun 2023</Citation></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, Berlit P, Berner R, Böing S, Brinkmann F, Frank U, Franke C, Glöckl R, Gogoll C, Häuser W, Hohberger B, Huber G, Hummel T, Köllner V, Krause S, Kronsbein J, Maibaum T, Otto-Thöne A, Pecks U, Peters EMJ, Peters S, Pfeifer M, Platz T, Pletz M, Powitz F, Rabe KF, Scheibenbogen C, Schneider D, Stallmach A, Stegbauer M, Tenenbaum T, Töpfner N, von Versen-Höynck F, Wagner HO, Waller C, Widmann CN, Winterholler C, Wirtz H, Zwick R (2022) S1-Leitlinie Long-/Post-COVID. Pneumologie 76:855–907. https://doi.org/10.1055/a-1946-3230</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1946-3230</ArticleId><ArticleId IdType="pubmed">36479679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B, Lin K, Mansur RB, Ho RC, Rosenblat JD, Miskowiak KW, Vinberg M, Maletic V, McIntyre RS (2022) Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun 101:93–135. https://doi.org/10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Peper M, Schott J (2021) Neuropsychologische Störungen Bei coronavirusassoziierten Erkrankungen: Erscheinungsbild, Diagnostik Und Rehabilitation. Z Für Neuropsychol 32:195–221. https://doi.org/10.1024/1016-264X/a000342</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/1016-264X/a000342</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, Mazibuko N, Williams SCR, Barnby JM, Hellyer P, Mehta MA (2021) Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine 39:101044. https://doi.org/10.1016/j.eclinm.2021.101044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId><ArticleId IdType="pmc">8298139</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, Lange F, Andersson JLR, Griffanti L, Duff E, Jbabdi S, Taschler B, Keating P, Winkler AM, Collins R, Matthews PM, Allen N, Miller KL, Nichols TE, Smith SM (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604:697–707. https://doi.org/10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId><ArticleId IdType="pmc">9046077</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P, Ballesteros AB, Yeung SP, Liu R, Saha A, Curtis L, Kaser M, Haggard MP, Cheke LG (2021) COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication from the COVID and Cognition Study. 2021.10.27.21265563</Citation></Reference><Reference><Citation>Weerahandi H, Hochman KA, Simon E, Blaum C, Chodosh J, Duan E, Garry K, Kahan T, Karmen-Tuohy SL, Karpel HC, Mendoza F, Prete AM, Quintana L, Rutishauser J, Santos Martinez L, Shah K, Sharma S, Simon E, Stirniman AZ, Howitz LI (2021) Post-discharge Health Status and symptoms in patients with severe COVID-19. J Gen Intern Med 36:738–745. https://doi.org/10.1007/s11606-020-06338-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-06338-4</ArticleId><ArticleId IdType="pubmed">33443703</ArticleId><ArticleId IdType="pmc">7808113</ArticleId></ArticleIdList></Reference><Reference><Citation>Janiri D, Carfì A, Kotzalidis GD, Bernabei R, Landi F, Sani G (2021) Posttraumatic stress disorder in patients after severe COVID-19 infection. JAMA Psychiatry 78:567. https://doi.org/10.1001/jamapsychiatry.2021.0109</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0109</ArticleId><ArticleId IdType="pubmed">33599709</ArticleId><ArticleId IdType="pmc">7893542</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong F, Liu H, Dai N, Yang M, Liu J (2021) A living systematic review of the psychological problems in people suffering from COVID-19. J Affect Disord 292:172–188. https://doi.org/10.1016/j.jad.2021.05.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.05.060</ArticleId><ArticleId IdType="pubmed">34126309</ArticleId><ArticleId IdType="pmc">8169237</ArticleId></ArticleIdList></Reference><Reference><Citation>Irazoki E, Contreras-Somoza LM, Toribio-Guzmán JM, Jenaro-Río C, van der Roest H, Franco-Martín MA (2020) Technologies for Cognitive Training and Cognitive Rehabilitation for people with mild cognitive impairment and dementia. A systematic review. Front Psychol 11:648. https://doi.org/10.3389/fpsyg.2020.00648</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2020.00648</ArticleId><ArticleId IdType="pubmed">32373018</ArticleId><ArticleId IdType="pmc">7179695</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini A, Vaezmousavi M, Shirvani H (2022) The effectiveness of cognitive-motor training on reconstructing cognitive health components in older male adults, recovered from the COVID-19. Neurol Sci 43:1395–1403. https://doi.org/10.1007/s10072-021-05502-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05502-w</ArticleId><ArticleId IdType="pubmed">34328579</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavendish BA, Lima A, Bertola L, Charvet L, Bikson M, Brunoni AR, Vidal KS (2022) Combination of transcranial direct current stimulation with online cognitive training improves symptoms of Post-acute Sequelae of COVID-19: a case series. Brain Stimulat 15:1375–1377. https://doi.org/10.1016/j.brs.2022.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2022.09.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V, Fonsmark L, Christensen RHB, Amiri M, Merie C, Lebech A, Katzenstein T, Bang LE, Kjærgaard J, Kondziella D, Benros ME (2022) Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for Non–COVID-19 illness. JAMA Psychiatry 79:486–497. https://doi.org/10.1001/jamapsychiatry.2022.0284</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.0284</ArticleId><ArticleId IdType="pubmed">35319743</ArticleId><ArticleId IdType="pmc">8943626</ArticleId></ArticleIdList></Reference><Reference><Citation>Akin-Sari B, Inozu M, Haciomeroglu AB, Trak E, Tufan D, Doron G (2022) Cognitive training using a mobile app as a coping tool against COVID-19 distress: a crossover randomized controlled trial. J Affect Disord 311:604–613. https://doi.org/10.1016/j.jad.2022.05.118</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.05.118</ArticleId><ArticleId IdType="pubmed">35636516</ArticleId><ArticleId IdType="pmc">9137239</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Wang L, Zhu Y, Zeng Y (2021) Efficacy of cognitive behavioral therapy on mood and quality of life for patients with COVID-19: a protocol for systematic review and meta-analysis. Med (Baltim) 100:e25512. https://doi.org/10.1097/MD.0000000000025512</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000025512</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroon S, Nirantharakumar K, Hughes SE, Subramanian A, Aiyegbusi OL, Davies EH, Myles P, Williams T, Turner G, Chandan JS, McMullan C, Lord J, Wraith DC, McGee K, Denniston AK, Taverner T, Jackson LJ, Sapey E, Gkoutos G, Gokhale K, Leggett E, Iles C, Frost C, McNamara G, Bamford A, Marshall T, Zemedikun DT, Price G, Marwaha S, Simms-Williams N, Brown K, Walker A, Jones K, Matthews K, Camaradou J, Saint-Cricq M, Kumar S, Alder Y, Stanton DE, Agyen L, Baber M, Blaize H, Calvert M (2022) Therapies for long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (the TLC study). BMJ Open 12:e060413. https://doi.org/10.1136/bmjopen-2021-060413</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-060413</ArticleId><ArticleId IdType="pubmed">35473737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Leber A, Jawad MY, Yu M, Lui LMW, Subramaniapillai M, Di Vincenzo JD, Gill H, Rodrigues NB, Cao B, Lee Y, Lin K, Mansur RB, Ho R, Burke MJ, Rosenblat JD, McIntyre RS (2022) Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research. Infect Dis 54:467–477. https://doi.org/10.1080/23744235.2022.2043560</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2022.2043560</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Qiao D, Xu Y, Zhao W, Yang Y, Wen D, Li X, Nie X, Dong Y, Tang S, Jiang Y, Wang Y, Zhao J, Xu Y (2021) The efficacy of computerized cognitive behavioral therapy for depressive and anxiety symptoms in patients with COVID-19: Randomized Controlled Trial. J Med Internet Res 23:e26883. https://doi.org/10.2196/26883</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/26883</ArticleId><ArticleId IdType="pubmed">33900931</ArticleId><ArticleId IdType="pmc">8128049</ArticleId></ArticleIdList></Reference><Reference><Citation>Adorjan K, Heindl B, Stubbe HC (2022) Post-COVIDLMU: Implementierung Und Evaluierung eines interdisziplinären und sektorenübergreifenden versorgungs- und Forschungsnetzwerks für eine evidenzgeleitete Behandlung Von Patienten Mit Schwerem Post-COVID-Syndrom. Nervenarzt 93:797–803. https://doi.org/10.1007/s00115-022-01322-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00115-022-01322-1</ArticleId><ArticleId IdType="pubmed">35695907</ArticleId><ArticleId IdType="pmc">9190193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachenbacher S, Heimkes F, Wunderlich N, Grosse-Wentrup F, Adorjan K, Stubbe H, Thomas A, Nedeljkovic A, Übleis A (2023) Psychotherapeutisches Konzept Der Post-COVID-Ambulanz Des LMU-Klinikums. Nervenarzt. https://doi.org/10.1007/s00115-023-01501-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00115-023-01501-8</ArticleId><ArticleId IdType="pubmed">37316618</ArticleId></ArticleIdList></Reference><Reference><Citation>Schadt C (2005) Fresh minder 2. [Software]. Fresh Minder Vertrieb, Besigheim. www.freshminder.de</Citation></Reference><Reference><Citation>Hautzinger M, Keller F, Kühner C (2006) Beck Depressions-Inventar (BDI-II). Revision. Frankf Am Main Test Serv Harcourt</Citation></Reference><Reference><Citation>Randolph C, Tierney MC, Mohr E, Chase TN (1998) The repeatable battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 20:310–319. https://doi.org/10.1076/jcen.20.3.310.823</Citation><ArticleIdList><ArticleId IdType="doi">10.1076/jcen.20.3.310.823</ArticleId><ArticleId IdType="pubmed">9845158</ArticleId></ArticleIdList></Reference><Reference><Citation>Brickenkamp R, Schmidt-Atzert L, Liepmann D (2010) Test d2-Revision: Aufmerksamkeits-Und Konzentrationstest. Hogrefe, Goettingen</Citation></Reference><Reference><Citation>Gold JM (1997) Auditory Working Memory and Wisconsin Card sorting test performance in Schizophrenia. Arch Gen Psychiatry 54:159. https://doi.org/10.1001/archpsyc.1997.01830140071013</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.1997.01830140071013</ArticleId><ArticleId IdType="pubmed">9040284</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitan RM (1958) Validity of the trail making test as an Indicator of Organic Brain damage. Percept Mot Skills 8:271–276. https://doi.org/10.2466/pms.1958.8.3.271</Citation><ArticleIdList><ArticleId IdType="doi">10.2466/pms.1958.8.3.271</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J (1988) Statistical power analysis for the behavioral sciences. J Am Stat Assoc 84:19–74</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>